These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8204800)

  • 41. The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning.
    Vegh A; Papp JG; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Dec; 107(4):910-1. PubMed ID: 1361401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease.
    Cohen MV; Downey JM
    Annu Rev Med; 1996; 47():21-9. PubMed ID: 8712775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preconditioning and its potential role in myocardial protection during cardiac surgery.
    Lasley RD; Mentzer RM
    J Card Surg; 1995 Jul; 10(4 Pt 1):349-53. PubMed ID: 7549193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial, neural and vascular aspects of ischemic preconditioning.
    Losano G; Gattullo D; Pagliaro P
    Life Sci; 1996; 59(15):1185-92. PubMed ID: 8845004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty.
    Airaksinen KE; Huikuri HV
    J Am Coll Cardiol; 1997 Apr; 29(5):1035-8. PubMed ID: 9120156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic effect of heat adaptation in ischemic and reperfusion injury to the heart.
    Monastyrskaya EA; Belkina LM; Manukhina EB; Malyshev IY
    Bull Exp Biol Med; 2007 Jan; 143(1):9-11. PubMed ID: 18019000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathophysiology of myocardial circulation. III. Preliminary results of ischemia using ischemia ("ischemic preconditioning")].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 1995 Jan; 120(1-2):35-6. PubMed ID: 7821203
    [No Abstract]   [Full Text] [Related]  

  • 48. Remote ischemic conditioning.
    Heusch G; Bøtker HE; Przyklenk K; Redington A; Yellon D
    J Am Coll Cardiol; 2015 Jan; 65(2):177-95. PubMed ID: 25593060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target?
    Laude K; Thuillez C; Richard V
    Braz J Med Biol Res; 2001 Jan; 34(1):1-7. PubMed ID: 11151023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The antiarrhythmic effect and clinical consequences of ischemic preconditioning.
    Evrengul H; Seleci D; Tanriverdi H; Kaftan A
    Coron Artery Dis; 2006 May; 17(3):283-8. PubMed ID: 16728880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning.
    Pan HL; Chen SR; Scicli GM; Carretero OA
    Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H116-21. PubMed ID: 10899048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is oxytocin a therapeutic factor for ischemic heart disease?
    Alizadeh AM; Mirzabeglo P
    Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of gap junctions by nitric oxide influences the generation of arrhythmias resulting from acute ischemia and reperfusion in vivo.
    Végh A; Gönczi M; Miskolczi G; Kovács M
    Front Pharmacol; 2013; 4():76. PubMed ID: 23785332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remote preconditioning-endocrine factors in organ protection against ischemic injury.
    Bolte CS; Liao S; Gross GJ; Schultz Jel J
    Endocr Metab Immune Disord Drug Targets; 2007 Sep; 7(3):167-75. PubMed ID: 17897043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous myocardial protective (antiarrhythmic) substances.
    Parratt J
    Cardiovasc Res; 1993 May; 27(5):693-702. PubMed ID: 8348567
    [No Abstract]   [Full Text] [Related]  

  • 57. Nitric oxide: an endogenous cardioprotectant?
    Pabla R; Curtis MJ
    EXS; 1996; 76():71-85. PubMed ID: 8805789
    [No Abstract]   [Full Text] [Related]  

  • 58. Gene expression profiling--a new approach in the study of myocardial ischemia.
    Simkhovich BZ; Kloner RA; Poizat C; Marjoram P; Kedes LH
    Cardiovasc Pathol; 2003; 12(4):180-5. PubMed ID: 12826286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological induction of delayed and prolonged cardiac protection: The role of prostanoids.
    Szekeres L
    Exp Clin Cardiol; 2004; 9(1):7-12. PubMed ID: 19641689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preconditioning stimuli and inadvertent preconditioning.
    Kloner RA; Przyklenk K; Whittaker P; Hale S
    J Mol Cell Cardiol; 1995 Feb; 27(2):743-7. PubMed ID: 7776379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.